nach oben

Medical Microbiology and Immunology

Erschienen in:

28.05.2020 | Review

Tetraspanin 7 and its closest paralog tetraspanin 6: membrane organizers with key functions in brain development, viral infection, innate immunity, diabetes and cancer

verfasst von: Brieuc P. Perot, Mickaël M. Ménager

Erschienen in: Medical Microbiology and Immunology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Tetraspanin (TSPAN) protein family forms a family of transmembrane proteins that act as organizers/scaffold for other proteins. TSPANs are primarily present on plasma membranes although they are also found in other biological membranes. They are organized in tetraspanin-enriched microdomains (TEMs), which allow spatiotemporal tuning of protein functions through the control of their membrane localization. TSPAN6 and TSPAN7 are close paralogs expressed in different tissues, TSPAN7 being highly expressed in the brain. Their functions only started to be unveiled in the late 2000’s and are still poorly understood. Here, we introduce how TSPAN7 was first highlighted has a protein mutated in some forms of X-linked mental retardation, which was later proposed to be caused by defects in neuronal morphogenesis and synaptic transmission. We then discuss the impacts TSPAN7 has on cell morphology of dendritic cells and osteoclasts, through rearrangement of actin cytoskeleton and how TSPAN7 was shown to be a target of autoantibody in patients suffering from type 1 diabetes. Finally, we are addressing the double edge sword that is TSPAN7 in cancer. In the second part of this review, we address the known roles of TSPAN6 and how this protein was shown to participate in synaptic transmission and in amyloid precursor protein secretion, which may contribute to Alzheimer’s disease pathology. We conclude this review by discussing the anti-inflammatory effect of TSPAN6.

Charrin S, Jouannet S, Boucheix C, Rubinstein E (2014) Tetraspanins at a glance. J Cell Sci 127:3641–3648. https://doi.org/10.1242/jcs.154906CrossRefPubMed

Hemler ME (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6:801–811. https://doi.org/10.1038/nrm1736CrossRefPubMed

Termini CM, Gillette JM (2017) Tetraspanins function as regulators of cellular signaling. Front Cell Dev Biol 5:34. https://doi.org/10.3389/fcell.2017.00034CrossRefPubMedPubMedCentral

Bassani S, Passafaro M (2012) TSPAN7: a new player in excitatory synapse maturation and function. Bioarchitecture 2:95–97. https://doi.org/10.4161/bioa.20829CrossRefPubMedPubMedCentral

Bassani S, Cingolani LA, Valnegri P et al (2012) The X-linked intellectual disability protein TSPAN7 regulates excitatory synapse development and AMPAR trafficking. Neuron 73:1143–1158. https://doi.org/10.1016/j.neuron.2012.01.021CrossRefPubMedPubMedCentral

Hemler ME (2008) Targeting of tetraspanin proteins–potential benefits and strategies. Nat Rev Drug Discov 7:747–758. https://doi.org/10.1038/nrd2659CrossRefPubMedPubMedCentral

Garcia-España A, Chung P-J, Sarkar IN et al (2008) Appearance of new tetraspanin genes during vertebrate evolution. Genomics 91:326–334. https://doi.org/10.1016/j.ygeno.2007.12.005CrossRefPubMed

Lu J, Li J, Liu S et al (2017) Exosomal tetraspanins mediate cancer metastasis by altering host microenvironment. Oncotarget 8:62803–62815. https://doi.org/10.18632/oncotarget.19119CrossRefPubMedPubMedCentral

Reyes R, Cardeñes B, Machado-Pineda Y, Cabañas C (2018) Tetraspanin CD9: a key regulator of cell adhesion in the immune system. Front Immunol 9:863. https://doi.org/10.3389/fimmu.2018.00863CrossRefPubMedPubMedCentral

10.

Pileri P, Uematsu Y, Campagnoli S et al (1998) Binding of hepatitis C virus to CD81. Science 282:938–941. https://doi.org/10.1126/science.282.5390.938CrossRefPubMed

11.

Suárez H, Rocha-Perugini V, Álvarez S, Yáñez-Mó M (2018) Tetraspanins, another piece in the HIV-1 replication puzzle. Front Immunol 9:1811. https://doi.org/10.3389/fimmu.2018.01811CrossRefPubMedPubMedCentral

12.

Fagerberg L, Hallström BM, Oksvold P et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13:397–406. https://doi.org/10.1074/mcp.M113.035600CrossRefPubMed

13.

Zemni R, Bienvenu T, Vinet MC et al (2000) A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet 24:167–170. https://doi.org/10.1038/72829CrossRefPubMed

14.

Abidi FE, Holinski-Feder E, Rittinger O et al (2002) A novel 2 bp deletion in the TM4SF2 gene is associated with MRX58. J Med Genet 39:430–433. https://doi.org/10.1136/jmg.39.6.430CrossRefPubMedPubMedCentral

15.

da Maranduba CM, Sá Moreira E, Müller Orabona G et al (2004) Does the P172H mutation at the TM4SF2 gene cause X-linked mental retardation? Am J Med Genet A 124A:413–415. https://doi.org/10.1002/ajmg.a.20401CrossRefPubMed

16.

Boda B, Mas C, Muller D (2002) Activity-dependent regulation of genes implicated in X-linked non-specific mental retardation. Neuroscience 114:13–17. https://doi.org/10.1016/s0306-4522(02)00218-xCrossRefPubMed

17.

Guo M, Huang T, Cui Y et al (2008) PrPC interacts with tetraspanin-7 through bovine PrP154-182 containing alpha-helix 1. Biochem Biophys Res Commun 365:154–157. https://doi.org/10.1016/j.bbrc.2007.10.160CrossRefPubMed

18.

Perez JL, Khatri L, Chang C et al (2001) PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2. J Neurosci 21:5417–5428CrossRefPubMedPubMedCentral

19.

Lee S-A, Suh Y, Lee S et al (2017) Functional expression of dopamine D2 receptor is regulated by tetraspanin 7-mediated postendocytic trafficking. FASEB J 31:2301–2313. https://doi.org/10.1096/fj.201600755RRCrossRefPubMed

20.

Usardi A, Iyer K, Sigoillot SM et al (2017) The immunoglobulin-like superfamily member IGSF3 is a developmentally regulated protein that controls neuronal morphogenesis. Dev Neurobiol 77:75–92. https://doi.org/10.1002/dneu.22412CrossRefPubMed

21.

Grozeva D, Carss K, Spasic-Boskovic O et al (2015) Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability. Hum Mutat 36:1197–1204. https://doi.org/10.1002/humu.22901CrossRefPubMedPubMedCentral

22.

Guilmatre A, Dubourg C, Mosca A-L et al (2009) Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66:947–956. https://doi.org/10.1001/archgenpsychiatry.2009.80CrossRefPubMedPubMedCentral

23.

Piton A, Gauthier J, Hamdan FF et al (2011) Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry 16:867–880. https://doi.org/10.1038/mp.2010.54CrossRefPubMed

24.

Merad M, Sathe P, Helft J et al (2013) The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563–604. https://doi.org/10.1146/annurev-immunol-020711-074950CrossRefPubMed

25.

Ahmed Z, Kawamura T, Shimada S, Piguet V (2015) The role of human dendritic cells in HIV-1 infection. J Invest Dermatol 135:1225–1233. https://doi.org/10.1038/jid.2014.490CrossRefPubMed

26.

Bertram KM, Tong O, Royle C et al (2019) Manipulation of mononuclear phagocytes by HIV: implications for early transmission events. Front Immunol 10:2263. https://doi.org/10.3389/fimmu.2019.02263CrossRefPubMedPubMedCentral

27.

Wu L, KewalRamani VN (2006) Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 6:859–868. https://doi.org/10.1038/nri1960CrossRefPubMedPubMedCentral

28.

Bracq L, Xie M, Benichou S, Bouchet J (2018) Mechanisms for cell-to-cell transmission of HIV-1. Front Immunol 9:260. https://doi.org/10.3389/fimmu.2018.00260CrossRefPubMedPubMedCentral

29.

Kijewski SD, Gummuluru S (2015) A mechanistic overview of dendritic cell-mediated HIV-1transinfection: the story so far. Future Virol 10:257–269. https://doi.org/10.2217/fvl.15.2CrossRefPubMedPubMedCentral

30.

Ménager MM, Littman DR (2016) Actin dynamics regulates dendritic cell-mediated transfer of HIV-1 to T cells. Cell 164:695–709. https://doi.org/10.1016/j.cell.2015.12.036CrossRefPubMedPubMedCentral

31.

Wiley RD, Gummuluru S (2006) Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci USA 103:738–743. https://doi.org/10.1073/pnas.0507995103CrossRefPubMedPubMedCentral

32.

Perot BP, García-Paredes V, Luka M, Ménager MM (2020) Dendritic cell maturation regulates TSPAN7 function in HIV-1 transfer to CD4 + T lymphocytes. Front Cell Infect Microbiol 10:70. https://doi.org/10.3389/fcimb.2020.00070CrossRefPubMedPubMedCentral

33.

Haller C, Müller B, Fritz JV et al (2014) HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. J Virol 88:14241–14257. https://doi.org/10.1128/JVI.02333-14CrossRefPubMedPubMedCentral

34.

Kammula EC, Mötter J, Gorgels A et al (2012) Brain transcriptome-wide screen for HIV-1 Nef protein interaction partners reveals various membrane-associated proteins. PLoS ONE 7:e51578. https://doi.org/10.1371/journal.pone.0051578CrossRefPubMedPubMedCentral

35.

Sato K, Aoki J, Misawa N et al (2008) Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J Virol 82:1021–1033. https://doi.org/10.1128/JVI.01044-07CrossRefPubMed

36.

Wang L, Liu L, Che Y et al (2010) Egress of HSV-1 capsid requires the interaction of VP26 and a cellular tetraspanin membrane protein. Virol J 7:156. https://doi.org/10.1186/1743-422X-7-156CrossRefPubMedPubMedCentral

37.

McDonald D (2010) Dendritic cells and HIV-1 trans-infection. Viruses 2:1704–1717. https://doi.org/10.3390/v2081704CrossRefPubMedPubMedCentral

38.

Kwon J-O, Lee YD, Kim H et al (2016) Tetraspanin 7 regulates sealing zone formation and the bone-resorbing activity of osteoclasts. Biochem Biophys Res Commun 477:1078–1084. https://doi.org/10.1016/j.bbrc.2016.07.046CrossRefPubMed

39.

Jurdic P, Saltel F, Chabadel A, Destaing O (2006) Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol 85:195–202. https://doi.org/10.1016/j.ejcb.2005.09.008CrossRefPubMed

40.

Burrack AL, Martinov T, Fife BT (2017) T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol (Lausanne) 8:343. https://doi.org/10.3389/fendo.2017.00343CrossRefPubMed

41.

Hald J, Galbo T, Rescan C et al (2012) Pancreatic islet and progenitor cell surface markers with cell sorting potential. Diabetologia 55:154–165. https://doi.org/10.1007/s00125-011-2295-1CrossRefPubMed

42.

McLaughlin KA, Richardson CC, Ravishankar A et al (2016) Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes. Diabetes 65:1690–1698. https://doi.org/10.2337/db15-1058CrossRefPubMed

43.

Walther D, Eugster A, Jergens S et al (2016) Tetraspanin 7 autoantibodies in type 1 diabetes. Diabetologia 59:1973–1976. https://doi.org/10.1007/s00125-016-3997-1CrossRefPubMed

44.

Eugster A, Kraus G, Lidzba V et al (2019) Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes. Diabetologia 62:805–810. https://doi.org/10.1007/s00125-019-4832-2CrossRefPubMed

45.

McLaughlin KA, Tombs MA, Christie MR (2020) Autoimmunity to tetraspanin-7 in type 1 diabetes. Med Microbiol Immunol. https://doi.org/10.1007/s00430-020-00674-2CrossRefPubMedPubMedCentral

46.

Thurner L, Müller A, Cérutti M et al (2011) Wegener’s granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin. J Autoimmun 36:87–90. https://doi.org/10.1016/j.jaut.2010.09.002CrossRefPubMed

47.

Ji G, Liang H, Wang F et al (2019) TSPAN12 precedes tumor proliferation by cell cycle control in ovarian cancer. Mol Cells 42:557–567. https://doi.org/10.14348/molcells.2019.0015CrossRefPubMedPubMedCentral

48.

Vences-Catalán F, Levy S (2018) Immune targeting of tetraspanins involved in cell invasion and metastasis. Front Immunol 9:1277. https://doi.org/10.3389/fimmu.2018.01277CrossRefPubMedPubMedCentral

49.

Hemler ME (2014) Tetraspanin proteins promote multiple cancer stages. Nat Rev Cancer 14:49–60. https://doi.org/10.1038/nrc3640CrossRefPubMed

50.

Schaper F, van Spriel AB (2018) antitumor immunity is controlled by tetraspanin proteins. Front Immunol 9:1185. https://doi.org/10.3389/fimmu.2018.01185CrossRefPubMedPubMedCentral

51.

Cowan AJ, Allen C, Barac A et al (2018) Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol 4:1221–1227. https://doi.org/10.1001/jamaoncol.2018.2128CrossRefPubMedPubMedCentral

52.

Cheong CM, Chow AWS, Fitter S et al (2015) Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo. Exp Cell Res 332:24–38. https://doi.org/10.1016/j.yexcr.2015.01.006CrossRefPubMed

53.

Chakraborty S (2014) In silico analysis identifies genes common between five primary gastrointestinal cancer sites with potential clinical applications. Ann Gastroenterol 27:231–236PubMedPubMedCentral

54.

Takagi S, Fujikawa K, Imai T et al (1995) Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily. Int J Cancer 61:706–715. https://doi.org/10.1002/ijc.2910610519CrossRefPubMed

55.

Wuttig D, Baier B, Fuessel S et al (2009) Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patient. Int J Cancer 125:474–482. https://doi.org/10.1002/ijc.24353CrossRefPubMed

56.

Wuttig D, Zastrow S, Füssel S et al (2012) CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases. Int J Cancer 131:E693–E704. https://doi.org/10.1002/ijc.27419CrossRefPubMed

57.

Nichols L, Saunders R, Knollmann FD (2012) Causes of death of patients with lung cancer. Arch Pathol Lab Med 136:1552–1557. https://doi.org/10.5858/arpa.2011-0521-OACrossRefPubMed

58.

Wang X, Lin M, Zhao J et al (2018) TSPAN7 promotes the migration and proliferation of lung cancer cells via epithelial-to-mesenchymal transition. Onco Targets Ther 11:8815–8822. https://doi.org/10.2147/OTT.S167902CrossRefPubMedPubMedCentral

59.

Xiao D, He J (2010) Epithelial mesenchymal transition and lung cancer. J Thorac Dis 2:154–159. https://doi.org/10.3978/j.issn.2072-1439.2010.02.03.7CrossRefPubMedPubMedCentral

60.

Pérez-Bercoff A, Makino T, McLysaght A (2010) Duplicability of self-interacting human genes. BMC Evol Biol 10:160. https://doi.org/10.1186/1471-2148-10-160CrossRefPubMedPubMedCentral

61.

Salas IH, Callaerts-Vegh Z, Arranz AM et al (2017) Tetraspanin 6: a novel regulator of hippocampal synaptic transmission and long term plasticity. PLoS ONE 12:e0171968. https://doi.org/10.1371/journal.pone.0171968CrossRefPubMedPubMedCentral

62.

Scheltens P, Blennow K, Breteler MMB et al (2016) Alzheimer’s disease. Lancet 388:505–517. https://doi.org/10.1016/S0140-6736(15)01124-1CrossRefPubMed

63.

Seipold L, Saftig P (2016) The emerging role of tetraspanins in the proteolytic processing of the amyloid precursor protein. Front Mol Neurosci 9:149. https://doi.org/10.3389/fnmol.2016.00149CrossRefPubMedPubMedCentral

64.

Blalock EM, Geddes JW, Chen KC et al (2004) Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101:2173–2178. https://doi.org/10.1073/pnas.0308512100CrossRefPubMedPubMedCentral

65.

Bossers K, Wirz KTS, Meerhoff GF et al (2010) Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer’s disease. Brain 133:3699–3723. https://doi.org/10.1093/brain/awq258CrossRefPubMed

66.

Miller JA, Woltjer RL, Goodenbour JM et al (2013) Genes and pathways underlying regional and cell type changes in Alzheimer’s disease. Genome Med 5:48. https://doi.org/10.1186/gm452CrossRefPubMedPubMedCentral

67.

Guix FX, Sannerud R, Berditchevski F et al (2017) Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments. Mol Neurodegener 12:25. https://doi.org/10.1186/s13024-017-0165-0CrossRefPubMedPubMedCentral

68.

Roh JS, Sohn DH (2018) Damage-associated molecular patterns in inflammatory diseases. Immune Netw 18:e27. https://doi.org/10.4110/in.2018.18.e27CrossRefPubMedPubMedCentral

69.

Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454:428–435. https://doi.org/10.1038/nature07201CrossRefPubMed

70.

Barton GM (2008) A calculated response: control of inflammation by the innate immune system. J Clin Investig 118:413–420. https://doi.org/10.1172/JCI34431CrossRefPubMedPubMedCentral

71.

Leifer CA, Medvedev AE (2016) Molecular mechanisms of regulation of Toll-like receptor signaling. J Leukoc Biol 100:927–941. https://doi.org/10.1189/jlb.2MR0316-117RRCrossRefPubMedPubMedCentral

72.

Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22:240–273. https://doi.org/10.1128/CMR.00046-08CrossRefPubMedPubMedCentral

73.

Loo Y-M, Gale M (2011) Immune signaling by RIG-I-like receptors. Immunity 34:680–692. https://doi.org/10.1016/j.immuni.2011.05.003CrossRefPubMedPubMedCentral

74.

Saiz ML, Rocha-Perugini V, Sánchez-Madrid F (2018) Tetraspanins as organizers of antigen-presenting cell function. Front Immunol 9:1074. https://doi.org/10.3389/fimmu.2018.01074CrossRefPubMedPubMedCentral

75.

Wang Y, Tong X, Omoregie ES et al (2012) Tetraspanin 6 (TSPAN6) negatively regulates retinoic acid-inducible gene I-like receptor-mediated immune signaling in a ubiquitination-dependent manner. J Biol Chem 287:34626–34634. https://doi.org/10.1074/jbc.M112.390401CrossRefPubMedPubMedCentral

Titel: Tetraspanin 7 and its closest paralog tetraspanin 6: membrane organizers with key functions in brain development, viral infection, innate immunity, diabetes and cancer
verfasst von: Brieuc P. Perot
Mickaël M. Ménager
Publikationsdatum: 28.05.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Medical Microbiology and Immunology / Ausgabe 4/2020
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI: https://doi.org/10.1007/s00430-020-00681-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Recent advancements in the understanding of tetraspanin functions

Molecular mechanisms of dendritic cell migration in immunity and cancer

Tetraspanin CD53: an overlooked regulator of immune cell function

Tetraspanins in mammalian reproduction: spermatozoa, oocytes and embryos

Tetraspanin CD81 regulates HSV-1 infection